Symbols / ALC Stock $74.09 -1.04% Alcon Inc.

Healthcare • Medical Instruments & Supplies • Switzerland • NYQ
ALC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. David J. Endicott
Exch · Country NYQ · Switzerland
Market Cap 37.03B
Enterprise Value 39.75B
Income 980.00M
Sales 10.40B
FCF (ttm) 1.23B
Book/sh 45.20
Cash/sh 3.31
Employees 25,942
Insider 10d
IPO Apr 09, 2019
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 17.20%
P/E 37.42
Forward P/E 18.86
PEG 1.70
P/S 3.56
P/B 1.64
P/C
EV/EBITDA 17.05
EV/Sales 3.82
Quick Ratio 1.28
Current Ratio 2.12
Debt/Eq 23.81
LT Debt/Eq
EPS (ttm) 1.98
EPS next Y 3.93
EPS Growth -22.20%
Revenue Growth 8.60%
EPS Gr Q/Q -23.60%
Rev Gr Q/Q
Earnings (next) 2026-05-05
Earnings (prior) 2026-02-24
ROA 2.57%
ROE 4.50%
ROIC
Gross Margin 55.67%
Oper. Margin 11.70%
Profit Margin 9.42%
Shs Outstand 487.43M
Shs Float 486.10M
Insider Own 0.18%
Instit Own 67.47%
Short Float
Short Ratio 3.55
Short Interest 4.90M
52W High 98.56
vs 52W High -24.82%
52W Low 71.55
vs 52W Low 3.55%
Beta 0.74
Impl. Vol. 50.72%
Rel Volume 0.80
Avg Volume 1.67M
Volume 1.34M
Target (mean) $94.43
Tgt Median $96.00
Tgt Low $71.00
Tgt High $113.00
# Analysts 16
Recom Buy
Prev Close $74.87
Price $74.09
Change -1.04%
About

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$74.09
Low
$71.00
High
$113.00
Mean
$94.43

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-23 reit BTIG Buy → Buy $92
2026-03-09 main Stifel Hold → Hold $82
2026-02-26 main Barclays Equal-Weight → Equal-Weight $90
2026-02-26 up Wells Fargo Equal-Weight → Overweight $97
2026-02-26 main Needham Buy → Buy $100
2026-02-25 main BTIG Buy → Buy $92
2026-01-09 down Stifel Buy → Hold $80
2025-12-11 down B of A Securities Buy → Underperform $75
2025-11-24 reit BTIG Buy → Buy $91
2025-11-13 main Baird Outperform → Outperform $98
2025-11-12 main Needham Buy → Buy $98
2025-11-11 main Mizuho Outperform → Outperform $100
2025-10-21 main Keybanc Overweight → Overweight $91
2025-10-13 init Barclays — → Equal-Weight $86
2025-10-13 main BTIG Buy → Buy $91
2025-09-29 main Stifel Buy → Buy $85
2025-08-21 main Mizuho Outperform → Outperform $110
2025-08-21 main Morgan Stanley Equal-Weight → Equal-Weight $80
2025-08-21 main Baird Outperform → Outperform $95
2025-08-21 down JP Morgan Overweight → Neutral $78
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
10,401.00
+4.94%
9,911.00
+4.82%
9,455.00
+8.47%
8,717.00
Operating Revenue
10,319.00
+4.91%
9,836.00
+4.97%
9,370.00
+8.27%
8,654.00
Cost Of Revenue
4,656.00
+5.84%
4,399.00
+4.54%
4,208.00
+6.02%
3,969.00
Reconciled Cost Of Revenue
4,656.00
+5.84%
4,399.00
+4.54%
4,208.00
+6.02%
3,969.00
Gross Profit
5,745.00
+4.23%
5,512.00
+5.05%
5,247.00
+10.51%
4,748.00
Operating Expense
4,385.00
+6.98%
4,099.00
-2.59%
4,208.00
+3.24%
4,076.00
Research And Development
990.00
+13.01%
876.00
+5.80%
828.00
+17.95%
702.00
Selling General And Administration
3,449.00
+6.12%
3,250.00
+1.28%
3,209.00
+4.60%
3,068.00
Other Operating Expenses
-54.00
-100.00%
-27.00
-115.79%
171.00
-44.12%
306.00
Total Expenses
9,041.00
+6.39%
8,498.00
+0.97%
8,416.00
+4.61%
8,045.00
Operating Income
1,360.00
-3.75%
1,413.00
+36.00%
1,039.00
+54.61%
672.00
Total Operating Income As Reported
1,360.00
-3.75%
1,413.00
+36.00%
1,039.00
+54.61%
672.00
EBITDA
2,699.00
+0.86%
2,676.00
+19.36%
2,242.00
+30.35%
1,720.00
Normalized EBITDA
2,739.00
+1.26%
2,705.00
+17.92%
2,294.00
+27.52%
1,799.00
Reconciled Depreciation
1,335.00
+8.71%
1,228.00
+0.57%
1,221.00
+8.73%
1,123.00
EBIT
1,364.00
-5.80%
1,448.00
+41.82%
1,021.00
+71.02%
597.00
Total Unusual Items
-40.00
-37.93%
-29.00
+44.23%
-52.00
+34.18%
-79.00
Total Unusual Items Excluding Goodwill
-40.00
-37.93%
-29.00
+44.23%
-52.00
+34.18%
-79.00
Special Income Charges
-2.00
-300.00%
1.00
+107.69%
-13.00
+38.10%
-21.00
Other Special Charges
2.00
+300.00%
-1.00
-107.69%
13.00
-38.10%
21.00
Net Income
980.00
-3.73%
1,018.00
+4.52%
974.00
+190.75%
335.00
Pretax Income
1,160.00
-7.64%
1,256.00
+50.96%
832.00
+79.70%
463.00
Net Non Operating Interest Income Expense
-142.00
-18.33%
-120.00
+22.58%
-155.00
-19.23%
-130.00
Interest Expense Non Operating
204.00
+6.25%
192.00
+1.59%
189.00
+41.04%
134.00
Net Interest Income
-142.00
-18.33%
-120.00
+22.58%
-155.00
-19.23%
-130.00
Interest Expense
204.00
+6.25%
192.00
+1.59%
189.00
+41.04%
134.00
Interest Income Non Operating
74.00
-11.90%
84.00
+86.67%
45.00
+181.25%
16.00
Interest Income
74.00
-11.90%
84.00
+86.67%
45.00
+181.25%
16.00
Other Income Expense
-58.00
-56.76%
-37.00
+28.85%
-52.00
+34.18%
-79.00
Gain On Sale Of Security
-38.00
-26.67%
-30.00
+23.08%
-39.00
+32.76%
-58.00
Tax Provision
180.00
-24.37%
238.00
+267.61%
-142.00
-210.94%
128.00
Tax Rate For Calcs
0.00
-18.20%
0.00
+122.93%
0.00
-69.20%
0.00
Tax Effect Of Unusual Items
-6.20
-12.83%
-5.50
-24.33%
-4.42
+79.73%
-21.80
Net Income Including Noncontrolling Interests
980.00
-3.73%
1,018.00
+4.52%
974.00
+190.75%
335.00
Net Income From Continuing Operation Net Minority Interest
980.00
-3.73%
1,018.00
+4.52%
974.00
+190.75%
335.00
Net Income From Continuing And Discontinued Operation
980.00
-3.73%
1,018.00
+4.52%
974.00
+190.75%
335.00
Net Income Continuous Operations
980.00
-3.73%
1,018.00
+4.52%
974.00
+190.75%
335.00
Minority Interests
0.00
0.00
0.00
Normalized Income
1,013.80
-2.66%
1,041.50
+1.95%
1,021.58
+160.48%
392.20
Net Income Common Stockholders
980.00
-3.73%
1,018.00
+4.52%
974.00
+190.75%
335.00
Diluted EPS
2.05
+4.59%
1.96
+188.24%
0.68
Basic EPS
2.06
+4.04%
1.98
+191.18%
0.68
Basic Average Shares
494.40
+0.28%
493.00
+0.33%
491.40
Diluted Average Shares
497.50
+0.20%
496.50
+0.42%
494.40
Diluted NI Availto Com Stockholders
980.00
-3.73%
1,018.00
+4.52%
974.00
+190.75%
335.00
Earnings From Equity Interest
-18.00
-125.00%
-8.00
0.00
0.00
Total Other Finance Cost
12.00
+0.00%
12.00
+9.09%
11.00
-8.33%
12.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
31,555.00
+3.98%
30,347.00
+2.48%
29,614.00
+1.54%
29,165.00
Current Assets
6,449.00
+2.22%
6,309.00
+11.72%
5,647.00
+8.74%
5,193.00
Cash Cash Equivalents And Short Term Investments
1,830.00
+66.21%
1,101.00
+12.35%
980.00
Cash And Cash Equivalents
1,676.00
+53.20%
1,094.00
+11.63%
980.00
Cash Equivalents
879.00
-32.28%
1,298.00
+57.52%
824.00
+17.88%
699.00
Cash Financial
648.00
+71.43%
378.00
+40.00%
270.00
-3.91%
281.00
Other Short Term Investments
154.00
+2100.00%
7.00
0.00
Receivables
2,082.00
-1.33%
2,110.00
+6.08%
1,989.00
Accounts Receivable
1,853.00
-1.75%
1,886.00
+6.25%
1,775.00
Gross Accounts Receivable
2,129.00
+12.41%
1,894.00
-1.87%
1,930.00
+5.35%
1,832.00
Allowance For Doubtful Accounts Receivable
-50.00
-21.95%
-41.00
+6.82%
-44.00
+22.81%
-57.00
Other Receivables
147.00
+14.84%
128.00
+25.49%
102.00
Taxes Receivable
91.00
+10.98%
82.00
-14.58%
96.00
-14.29%
112.00
Inventory
2,391.00
+5.42%
2,268.00
-2.33%
2,322.00
+10.10%
2,109.00
Raw Materials
476.00
+8.68%
438.00
+0.92%
434.00
+0.23%
433.00
Work In Process
190.00
-4.52%
199.00
+1.02%
197.00
-1.99%
201.00
Finished Goods
1,725.00
+5.76%
1,631.00
-3.55%
1,691.00
+14.64%
1,475.00
Prepaid Assets
124.00
+5.98%
117.00
+4.46%
112.00
+4.67%
107.00
Hedging Assets Current
5.00
-58.33%
12.00
+500.00%
2.00
-75.00%
8.00
Other Current Assets
3,929.00
+0.43%
3,912.00
Total Non Current Assets
25,106.00
+4.44%
24,038.00
+0.30%
23,967.00
-0.02%
23,972.00
Net PPE
4,838.00
+2.43%
4,723.00
+6.95%
4,416.00
Gross PPE
8,037.00
+4.40%
7,698.00
+7.42%
7,166.00
Accumulated Depreciation
-3,199.00
-7.53%
-2,975.00
-8.18%
-2,750.00
Properties
0.00
0.00
0.00
Land And Improvements
66.00
+10.00%
60.00
+15.38%
52.00
+4.00%
50.00
Buildings And Improvements
3,043.00
+11.42%
2,731.00
+4.92%
2,603.00
+6.77%
2,438.00
Machinery Furniture Equipment
4,270.00
+7.04%
3,989.00
+7.99%
3,694.00
Construction In Progress
988.00
+5.11%
940.00
-8.11%
1,023.00
+7.12%
955.00
Other Properties
36.00
+16.13%
31.00
+6.90%
29.00
Goodwill And Other Intangible Assets
17,533.00
-2.52%
17,986.00
-3.38%
18,615.00
Goodwill
9,256.00
+3.47%
8,946.00
+0.22%
8,926.00
+0.00%
8,926.00
Other Intangible Assets
8,587.00
-5.22%
9,060.00
-6.49%
9,689.00
Investments And Advances
751.00
+135.42%
319.00
+195.37%
108.00
Long Term Equity Investment
293.00
+2830.00%
10.00
0.00
Non Current Accounts Receivable
149.00
-9.15%
164.00
+4.46%
157.00
Non Current Deferred Assets
660.00
+9.82%
601.00
-0.83%
606.00
+10.18%
550.00
Non Current Deferred Taxes Assets
458.00
+8.79%
421.00
-4.97%
443.00
+7.79%
411.00
Non Current Prepaid Assets
6.00
+0.00%
6.00
-25.00%
8.00
Other Non Current Assets
24,446.00
+4.31%
23,437.00
+19594.96%
119.00
+23.96%
96.00
Total Liabilities Net Minority Interest
31,555.00
+3.98%
30,347.00
+237.56%
8,990.00
-5.25%
9,488.00
Current Liabilities
3,049.00
+33.85%
2,278.00
-5.00%
2,398.00
-12.42%
2,738.00
Payables And Accrued Expenses
1,497.00
-6.50%
1,601.00
-7.78%
1,736.00
Payables
982.00
-7.79%
1,065.00
-11.25%
1,200.00
Accounts Payable
926.00
+19.79%
773.00
-4.69%
811.00
-5.81%
861.00
Other Payable
46.00
-33.33%
69.00
+4.55%
66.00
Current Accrued Expenses
537.00
+4.27%
515.00
-3.92%
536.00
+0.00%
536.00
Employee Benefits
611.00
-1.13%
618.00
+11.15%
556.00
Pensionand Other Post Retirement Benefit Plans Current
498.00
-6.21%
531.00
-3.45%
550.00
+18.28%
465.00
Total Tax Payable
163.00
-11.89%
185.00
-32.23%
273.00
Income Tax Payable
182.00
+75.00%
104.00
-8.77%
114.00
-34.86%
175.00
Current Debt And Capital Lease Obligation
169.00
+36.29%
124.00
-26.19%
168.00
Current Debt
101.00
+90.57%
53.00
-45.36%
97.00
Other Current Borrowings
34.00
+580.00%
5.00
-94.74%
95.00
Current Capital Lease Obligation
80.00
+17.65%
68.00
-4.23%
71.00
+0.00%
71.00
Current Deferred Liabilities
73.00
-6.41%
78.00
-12.36%
89.00
Current Deferred Revenue
84.00
+15.07%
73.00
-6.41%
78.00
-12.36%
89.00
Other Current Liabilities
4.00
-60.00%
10.00
+0.00%
10.00
Total Non Current Liabilities Net Minority Interest
6,471.00
-0.69%
6,516.00
-1.15%
6,592.00
-2.34%
6,750.00
Long Term Debt And Capital Lease Obligation
429.00
+0.00%
429.00
-91.44%
5,011.00
+2.27%
4,900.00
Long Term Debt
4,538.00
-2.95%
4,676.00
+2.97%
4,541.00
Long Term Capital Lease Obligation
429.00
+0.00%
429.00
+28.06%
335.00
-6.69%
359.00
Non Current Pension And Other Postretirement Benefit Plans
416.00
+2.46%
406.00
-6.45%
434.00
+9.60%
396.00
Non Current Deferred Liabilities
810.00
-2.29%
829.00
-22.09%
1,064.00
Non Current Deferred Revenue
91.00
+5.81%
86.00
+168.75%
32.00
Non Current Deferred Taxes Liabilities
724.00
-9.16%
797.00
-25.09%
1,064.00
Other Non Current Liabilities
6,631.00
+0.29%
6,612.00
+4834.33%
134.00
-41.74%
230.00
Stockholders Equity
22,014.00
+2.23%
21,533.00
+4.41%
20,624.00
+4.81%
19,677.00
Common Stock Equity
22,014.00
+2.23%
21,533.00
+4.41%
20,624.00
+4.81%
19,677.00
Capital Stock
20.00
+0.00%
20.00
+0.00%
20.00
Common Stock
20.00
+0.00%
20.00
+0.00%
20.00
Share Issued
499.73
+0.01%
499.70
+0.01%
499.64
+0.33%
497.99
Ordinary Shares Number
487.43
-1.45%
494.62
+0.28%
493.24
+0.64%
490.09
Treasury Shares Number
12.30
+141.95%
5.08
-20.57%
6.40
-18.99%
7.90
Gains Losses Not Affecting Retained Earnings
22,014.00
+2.23%
21,533.00
+4.51%
20,604.00
+4.82%
19,657.00
Minority Interest
1.00
0.00
Total Equity Gross Minority Interest
21,553.00
+4.50%
20,624.00
+4.81%
19,677.00
Total Capitalization
22,014.00
+2.23%
21,533.00
-14.89%
25,300.00
+4.47%
24,218.00
Working Capital
3,400.00
-15.65%
4,031.00
+24.07%
3,249.00
+32.34%
2,455.00
Invested Capital
26,192.00
+3.31%
25,353.00
+4.27%
24,315.00
Total Debt
509.00
+2.41%
497.00
-90.32%
5,135.00
+1.32%
5,068.00
Net Debt
2,963.00
-18.49%
3,635.00
-0.63%
3,658.00
Capital Lease Obligations
509.00
+2.41%
497.00
+22.41%
406.00
-5.58%
430.00
Net Tangible Assets
22,014.00
+2.23%
21,533.00
+716.26%
2,638.00
+148.40%
1,062.00
Tangible Book Value
22,014.00
+2.23%
21,533.00
+716.26%
2,638.00
+148.40%
1,062.00
Available For Sale Securities
457.00
+48.38%
308.00
+250.00%
88.00
Current Provisions
4.00
-88.57%
35.00
-87.04%
270.00
Financial Assets Designatedas Fair Value Through Profitor Loss Total
4.00
+300.00%
1.00
+0.00%
1.00
-95.00%
20.00
Interest Payable
34.00
+6.25%
32.00
+0.00%
32.00
+3.23%
31.00
Investmentin Financial Assets
458.00
+48.22%
309.00
+186.11%
108.00
Investmentsin Associatesat Cost
77.00
-73.72%
293.00
+2830.00%
10.00
0.00
Line Of Credit
65.00
-2.99%
67.00
+39.58%
48.00
+2300.00%
2.00
Non Current Note Receivables
46.00
+2.22%
45.00
+2.27%
44.00
+100.00%
22.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
2,271.00
+9.34%
2,077.00
+49.64%
1,388.00
+14.05%
1,217.00
Cash Flow From Continuing Operating Activities
2,271.00
+9.34%
2,077.00
+49.64%
1,388.00
+14.05%
1,217.00
Net Income From Continuing Operations
980.00
-3.73%
1,018.00
+4.52%
974.00
+190.75%
335.00
Depreciation Amortization Depletion
1,335.00
+8.71%
1,228.00
+0.57%
1,221.00
+8.73%
1,123.00
Depreciation
506.00
+6.30%
476.00
+0.00%
476.00
+16.67%
408.00
Amortization Cash Flow
829.00
+10.24%
752.00
+0.94%
745.00
+4.20%
715.00
Depreciation And Amortization
1,335.00
+8.71%
1,228.00
+0.57%
1,221.00
+8.73%
1,123.00
Amortization Of Intangibles
829.00
+10.24%
752.00
+0.94%
745.00
+4.20%
715.00
Other Non Cash Items
-30.00
-157.69%
52.00
+183.87%
-62.00
-159.05%
105.00
Stock Based Compensation
162.00
+8.00%
150.00
+4.17%
144.00
+2.86%
140.00
Provisionand Write Offof Assets
84.00
+61.54%
52.00
+147.62%
21.00
-88.77%
187.00
Deferred Tax
180.00
-24.37%
238.00
+267.61%
-142.00
-210.94%
128.00
Deferred Income Tax
180.00
-24.37%
238.00
+267.61%
-142.00
-210.94%
128.00
Operating Gains Losses
34.00
+203.03%
-33.00
-222.22%
27.00
+170.00%
10.00
Gain Loss On Sale Of PPE
16.00
+139.02%
-41.00
-251.85%
27.00
+170.00%
10.00
Change In Working Capital
-240.00
-26.98%
-189.00
+53.22%
-404.00
+22.61%
-522.00
Change In Receivables
-129.00
-134.55%
-55.00
+50.00%
-110.00
+32.93%
-164.00
Changes In Account Receivables
-129.00
-134.55%
-55.00
+50.00%
-110.00
+32.93%
-164.00
Change In Inventory
-156.00
-231.91%
-47.00
+82.66%
-271.00
-24.88%
-217.00
Change In Payables And Accrued Expense
116.00
+873.33%
-15.00
+70.59%
-51.00
-6.25%
-48.00
Change In Payable
116.00
+873.33%
-15.00
+70.59%
-51.00
-6.25%
-48.00
Change In Account Payable
116.00
+873.33%
-15.00
+70.59%
-51.00
-6.25%
-48.00
Change In Other Current Assets
-47.00
-67.86%
-28.00
-21.74%
-23.00
+63.49%
-63.00
Change In Other Current Liabilities
-24.00
+45.45%
-44.00
-186.27%
51.00
+270.00%
-30.00
Investing Cash Flow
-1,344.00
-15.17%
-1,167.00
-6.67%
-1,094.00
+41.34%
-1,865.00
Cash Flow From Continuing Investing Activities
-1,344.00
-15.17%
-1,167.00
-6.67%
-1,094.00
+41.34%
-1,865.00
Net PPE Purchase And Sale
-538.00
-13.74%
-473.00
+28.12%
-658.00
-3.46%
-636.00
Purchase Of PPE
-543.00
-14.80%
-473.00
+28.12%
-658.00
-3.46%
-636.00
Sale Of PPE
5.00
0.00
0.00
0.00
Capital Expenditure
-663.00
+1.04%
-670.00
+21.27%
-851.00
-14.23%
-745.00
Net Investment Purchase And Sale
22.00
+108.18%
-269.00
-16.45%
-231.00
-845.16%
31.00
Purchase Of Investment
-136.00
+51.08%
-278.00
-19.31%
-233.00
-366.00%
-50.00
Sale Of Investment
158.00
+1655.56%
9.00
+350.00%
2.00
-97.53%
81.00
Net Business Purchase And Sale
-700.00
-218.18%
-220.00
-2100.00%
-10.00
+98.50%
-666.00
Purchase Of Business
-700.00
-218.18%
-220.00
-2100.00%
-10.00
+98.50%
-666.00
Net Intangibles Purchase And Sale
-120.00
+39.09%
-197.00
-2.07%
-193.00
-77.06%
-109.00
Purchase Of Intangibles
-120.00
+39.09%
-197.00
-2.07%
-193.00
-77.06%
-109.00
Net Other Investing Changes
-8.00
+0.00%
-8.00
-300.00%
-2.00
+99.59%
-485.00
Financing Cash Flow
-1,119.00
-247.52%
-322.00
-52.61%
-211.00
-2537.50%
-8.00
Cash Flow From Continuing Financing Activities
-1,119.00
-247.52%
-322.00
-52.61%
-211.00
-2537.50%
-8.00
Net Issuance Payments Of Debt
-31.00
+77.37%
-137.00
-522.73%
-22.00
-110.58%
208.00
Issuance Of Debt
97.00
+64.41%
59.00
-44.34%
106.00
-95.90%
2,586.00
Repayment Of Debt
-128.00
+34.69%
-196.00
-53.13%
-128.00
+94.62%
-2,378.00
Long Term Debt Issuance
97.00
+64.41%
59.00
-44.34%
106.00
-95.90%
2,586.00
Long Term Debt Payments
-128.00
+34.69%
-196.00
-53.13%
-128.00
+94.62%
-2,378.00
Net Long Term Debt Issuance
-31.00
+77.37%
-137.00
-522.73%
-22.00
-110.58%
208.00
Short Term Debt Issuance
77.00
0.00
Short Term Debt Payments
-34.00
+19.05%
-42.00
Net Short Term Debt Issuance
43.00
+202.38%
-42.00
Net Common Stock Issuance
-676.00
0.00
0.00
Common Stock Payments
-676.00
0.00
0.00
Common Stock Dividend Paid
-166.00
-27.69%
-130.00
-12.07%
-116.00
-16.00%
-100.00
Cash Dividends Paid
-166.00
-27.69%
-130.00
-12.07%
-116.00
-16.00%
-100.00
Repurchase Of Capital Stock
-676.00
0.00
0.00
Net Other Financing Charges
-246.00
-347.27%
-55.00
+24.66%
-73.00
+37.07%
-116.00
Changes In Cash
-192.00
-132.65%
588.00
+608.43%
83.00
+112.65%
-656.00
Effect Of Exchange Rate Changes
43.00
+816.67%
-6.00
-119.35%
31.00
-49.18%
61.00
Beginning Cash Position
1,676.00
+53.20%
1,094.00
+11.63%
980.00
-37.78%
1,575.00
End Cash Position
1,527.00
-8.89%
1,676.00
+53.20%
1,094.00
+11.63%
980.00
Free Cash Flow
1,608.00
+14.29%
1,407.00
+162.01%
537.00
+13.77%
472.00
Amortization Of Securities
0.00
0.00
-100.00%
7.00
+150.00%
-14.00
Earnings Losses From Equity Investments
18.00
+125.00%
8.00
0.00
0.00
Interest Paid CFO
-190.00
-4.40%
-182.00
-3.41%
-176.00
-58.56%
-111.00
Interest Received CFO
63.00
-8.70%
69.00
+109.09%
33.00
+135.71%
14.00
Taxes Refund Paid
-107.00
+67.18%
-326.00
-27.84%
-255.00
-43.26%
-178.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category